Quick Answer
NEW YORK TIMES CO reported Research And Development Expense of $264.35 million for the year ending 2025.
- NEW YORK TIMES CO showed an increase of +6.5% in Research And Development Expense from 2024 to 2025.
- This data is from NEW YORK TIMES CO's annual report (Form 10-K), filed with the SEC on February 27, 2026.
- XBRL data for this metric is available from 2018 to 2025 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2019: $23.73 million | Q2 2019: $25.26 million | Q3 2019: $26.67 million | Q1 2020: $31.00 million | Q2 2020: $30.98 million | Q3 2020: $34.35 million | Q1 2021: $38.94 million | Q2 2021: $39.70 million | Q3 2021: $40.64 million | Q4 2021: $160.87 million | Q1 2022: $47.43 million | Q2 2022: $50.82 million | Q3 2022: $50.47 million | Q4 2022: $204.19 million | Q1 2023: $57.06 million | Q2 2023: $56.05 million | Q3 2023: $57.43 million | Q1 2024: $63.19 million | Q2 2024: $62.22 million | Q3 2024: $61.03 million | Q1 2025: $66.54 million | Q2 2025: $63.94 million | Q3 2025: $66.99 million.
- Over the full 8 years of available data (2018 to 2025), NEW YORK TIMES CO's Research And Development Expense has grown by 214.3%.
- Historical annual values: Fiscal year 2025: $264.35 million | Fiscal year 2024: $248.20 million | Fiscal year 2023: $228.80 million | Fiscal year 2022: $204.19 million | Fiscal year 2021: $160.87 million | Fiscal year 2020: $133.38 million | Fiscal year 2019: $106.42 million | Fiscal year 2018: $84.10 million.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: